Stephen Wilton
Director/Board Member at BIOSYENT INC.
Net worth: 16 679 $ as of 30/03/2024
Profile
Stephen Wilton is an Independent Director at BioSyent, Inc. since 2014.
Prior to this, he worked as an Executive Director-Business Development at AstraZeneca Pharmaceuticals LP from 1993 to 2010 and as a Vice President-Pharmacy Affairs at The Canadian Association of Chain Drug Stores from 2011 to 2012.
He completed his undergraduate degree at the University of Toronto and his MBA at The Schulich School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOSYENT INC.
0.02% | 26/03/2024 | 2,600 ( 0.02% ) | 16 679 $ | 30/03/2024 |
Stephen Wilton active positions
| Companies | Position | Start |
|---|---|---|
| BIOSYENT INC. | Director/Board Member | 15/01/2014 |
Former positions of Stephen Wilton
| Companies | Position | End |
|---|---|---|
| The Canadian Association of Chain Drug Stores | Corporate Officer/Principal | 31/12/2011 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | General Counsel | - |
Training of Stephen Wilton
| University of Toronto | Undergraduate Degree |
| The Schulich School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOSYENT INC. | Health Technology |
| Private companies | 2 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
| The Canadian Association of Chain Drug Stores |
- Stock Market
- Insiders
- Stephen Wilton
